Literature DB >> 7751844

PCR and immunocytochemical analyses of dystrophin-positive fibers in Duchenne muscular dystrophy.

M Uchino1, M Tokunaga, S Mita, E Uyama, Y Ando, H Teramoto, T Miike, M Ando.   

Abstract

Immunocytochemical studies on serial sections of muscles from 19 patients with Duchenne muscular dystrophy (DMD) were done using seven kinds of antidystrophin antibodies that span dystrophin. Fifteen of the patients were screened for intragenic deletions by the multiplex polymerase chain reaction (PCR); 7 were also tested, using Southern blots. Dystrophin-positive fibers were detected in 10 of the 19 patients, occurring with a frequency of 0.06-75.7%, as clusters or as single fibers in certain muscle bundles. In 7 of the 10 patients, the fibers stained with all antibodies from the N- through the C-terminal region. However, in one patient, there were dystrophin-positive fibers that stained with an N-terminal antibody (DYS-3) and an antibody specific to the rod region (DYS-1), but not with C-terminal antibody (DYS-2). In 2 patients, there were two kinds of fibers: one that did not stain with DYS-1 or DYS-2 and another that stained with all the antibodies used. Single-fiber PCR analysis in 2 patients showed that the genotype of dystrophin-positive fibers differed from that of dystrophin-negative fibers. These results suggest that the majority of dystrophin-positive fibers are of the same clonal origin, but that some are derived from plural reverse mutations, each with a different translation-frame-repairing modality and somatic mosaicism.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7751844     DOI: 10.1016/0022-510x(94)00245-j

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  9 in total

1.  Anti-dystrophin T cell responses in Duchenne muscular dystrophy: prevalence and a glucocorticoid treatment effect.

Authors:  Kevin M Flanigan; Katie Campbell; Laurence Viollet; Wei Wang; Ana Maria Gomez; Christopher M Walker; Jerry R Mendell
Journal:  Hum Gene Ther       Date:  2013-09       Impact factor: 5.695

2.  Inhibition of antigen presentation during AAV gene therapy using virus peptides.

Authors:  Wenwei Shao; Xiaojing Chen; Richard J Samulski; Matthew L Hirsch; Chengwen Li
Journal:  Hum Mol Genet       Date:  2018-02-15       Impact factor: 6.150

Review 3.  Molecular Therapies for Muscular Dystrophies.

Authors:  Ava Y Lin; Leo H Wang
Journal:  Curr Treat Options Neurol       Date:  2018-06-21       Impact factor: 3.598

4.  Polymerase chain reaction fiber analysis and somatic mosaicism in autopsied tissue from a man with Duchenne muscular dystrophy.

Authors:  M Uchino; M Tokunaga; T Yamashita; S Mita; A Hara; E Uyama; H Teramoto; H Naoe; M Ando
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

5.  Histologic muscular history in steroid-treated and untreated patients with Duchenne dystrophy.

Authors:  Lorenzo Peverelli; Silvia Testolin; Luisa Villa; Adele D'Amico; Stefania Petrini; Chiara Favero; Francesca Magri; Lucia Morandi; Marina Mora; Tiziana Mongini; Enrico Bertini; Monica Sciacco; Giacomo P Comi; Maurizio Moggio
Journal:  Neurology       Date:  2015-10-23       Impact factor: 9.910

6.  Revertant fibers in the mdx murine model of Duchenne muscular dystrophy: an age- and muscle-related reappraisal.

Authors:  Sarah R Pigozzo; Lorena Da Re; Chiara Romualdi; Pietro G Mazzara; Eva Galletta; Sue Fletcher; Stephen D Wilton; Libero Vitiello
Journal:  PLoS One       Date:  2013-08-28       Impact factor: 3.240

7.  Induction of revertant fibres in the mdx mouse using antisense oligonucleotides.

Authors:  Abbie M Fall; Russell Johnsen; Kaite Honeyman; Pat Iversen; Susan Fletcher; Stephen D Wilton
Journal:  Genet Vaccines Ther       Date:  2006-05-24

8.  Massive idiosyncratic exon skipping corrects the nonsense mutation in dystrophic mouse muscle and produces functional revertant fibers by clonal expansion.

Authors:  Q L Lu; G E Morris; S D Wilton; T Ly; O V Artem'yeva; P Strong; T A Partridge
Journal:  J Cell Biol       Date:  2000-03-06       Impact factor: 10.539

Review 9.  Revertant Phenomenon in DMD and LGMD2I and Its Therapeutic Implications: A Review of Study Under Mentorship of Terrence Partridge.

Authors:  Qi Long Lu
Journal:  J Neuromuscul Dis       Date:  2021
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.